Literature DB >> 34052429

Application of ultraviolet, visible, and infrared light imaging in protein-based biopharmaceutical formulation characterization and development studies.

Marieke E Klijn1, Jürgen Hubbuch2.   

Abstract

Imaging is increasingly more utilized as analytical technology in biopharmaceutical formulation research, with applications ranging from subvisible particle characterization to thermal stability screening and residual moisture analysis. This review offers a comprehensive overview of analytical imaging for scientists active in biopharmaceutical formulation research and development, where it presents the unique information provided by the ultraviolet (UV), visible (Vis), and infrared (IR) sections in the electromagnetic spectrum. The main body of this review consists of an outline of UV, Vis, and IR imaging techniques for several (bio)physical properties that are commonly determined during protein-based biopharmaceutical formulation characterization and development studies. The review concludes with a future perspective of applied imaging within the field of biopharmaceutical formulation research.
Copyright © 2021 The Authors. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Computer vision; Formulation development; High-throughput screening; Image processing; Machine learning; Protein analytics

Mesh:

Substances:

Year:  2021        PMID: 34052429     DOI: 10.1016/j.ejpb.2021.05.013

Source DB:  PubMed          Journal:  Eur J Pharm Biopharm        ISSN: 0939-6411            Impact factor:   5.571


  2 in total

Review 1.  Chemistry and Analysis of Organic Compounds in Dinosaurs.

Authors:  Mariam Tahoun; Marianne Engeser; Vigneshwaran Namasivayam; Paul Martin Sander; Christa E Müller
Journal:  Biology (Basel)       Date:  2022-04-27

2.  Infrared Thermography for Monitoring of Freeze Drying Processes-Part 2: Monitoring of Temperature on the Surface and Vertically in Cuvettes during Freeze Drying of a Pharmaceutical Formulation.

Authors:  Håkan Emteborg; Jean Charoud-Got; John Seghers
Journal:  Pharmaceutics       Date:  2022-05-07       Impact factor: 6.525

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.